IRREVERSIBLE INHIBITION OF RAT-LIVER MITOCHONDRIAL MAO-A AND MAO-B BY ENANTIOMERS OF DEPRENYL AND ALPHA-METHYLPARGYLINE

被引:5
作者
ROBINSON, JB
BOCCHINFUSO, R
KHALIL, A
机构
[1] Faculty of Pharmacy, University of Toronto, Toronto, Ontario
关键词
D O I
10.1111/j.2042-7158.1995.tb05803.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using rat liver mitochondrial monoamine oxidase (MAO) A and MAO B, the possible influence of stereochemical factors upon the irreversible inhibition by propargylamine derivatives has been studied using the enantiomers of deprenyl and of alpha-methylpargyline. Whether studying the inhibition of MAO A or MAO B, little difference was found among enantiomeric pairs in the first-order rate constant (k(2)) for formation of the enzyme inhibitor adduct. Similarly, and with the exception of (S)-D-(+)-deprenyl (k(2) = 0 or an extremely low value at MAO A), the computed value of k(2) for the individual enantiomers showed little variation between MAO A and MAO B. These results suggest that inhibitor selectivity towards a particular form of the enzyme is determined predominantly at the competitive phase of the inhibition.
引用
收藏
页码:324 / 328
页数:5
相关论文
共 21 条
[1]   SYNTHESIS, BIOLOGICAL EVALUATION AND QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP ANALYSIS OF NUCLEAR-SUBSTITUTED PARGYLINES AS COMPETITIVE INHIBITORS OF MAO-A AND MAO-B [J].
ALI, A ;
ROBINSON, JB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (11) :750-757
[2]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[3]   CONCENTRATION-DEPENDENCE OF THE OXIDATION OF TYRAMINE BY THE 2 FORMS OF RAT-LIVER MITOCHONDRIAL MONOAMINE-OXIDASE [J].
FOWLER, CJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (24) :3329-3332
[4]   THE NATURE OF THE INHIBITION OF RAT-LIVER MONOAMINE-OXIDASE TYPE-A AND TYPE-B BY THE ACETYLENIC INHIBITORS CLORGYLINE, L-DEPRENYL AND PARGYLINE [J].
FOWLER, CJ ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (22) :3555-3561
[5]   SOME OBSERVATIONS UPON A NEW INHIBITOR OF MONOAMINE OXIDASE IN BRAIN TISSUE [J].
JOHNSTON, JP .
BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1285-&
[6]  
KITZ R, 1962, J BIOL CHEM, V237, P3245
[7]   TOXICOLOGICAL DETECTION OF SELEGILINE AND ITS METABOLITES IN URINE USING FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA) AND GAS-CHROMATOGRAPHY MASS-SPECTROMETRY (GC-MS) AND DIFFERENTIATION BY ENANTIOSELECTIVE GC-MS OF THE INTAKE OF SELEGILINE FROM ABUSE OF METHAMPHETAMINE OR AMPHETAMINE [J].
MAURER, HH ;
KRAEMER, T .
ARCHIVES OF TOXICOLOGY, 1992, 66 (09) :675-678
[8]  
MAYCOCK AL, 1976, BIOCHEMISTRY-US, V115, P114
[9]   DEPRENYL IS METABOLIZED TO METHAMPHETAMINE AND AMPHETAMINE IN MAN [J].
REYNOLDS, GP ;
ELSWORTH, JD ;
BLAU, K ;
SANDLER, M ;
LEES, AJ ;
STERN, GM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (06) :542-544
[10]  
Richards L E, 1986, Prog Drug Res, V30, P205